{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:10:08Z","timestamp":1760256608495,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1006\/jaut.1999.0358","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T16:34:52Z","timestamp":1033922092000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of Experimental Autoimmune Encephalomyelitis With Adenylate Deaminase From"],"prefix":"10.1006","volume":"14","author":[{"given":"Vizma","family":"Nikolajeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daina","family":"Eze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaiga","family":"Petrina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indrikis","family":"Muiznieks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1987","series-title":"Immunology, immunopathology, and immunity","author":"Sell","key":"10.1006\/jaut.1999.0358_RF1"},{"key":"10.1006\/jaut.1999.0358_RF2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.4049\/jimmunol.114.5.1537","article-title":"Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic protein","volume":"114","author":"Bernard","year":"1975","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.1999.0358_RF3","first-page":"278","article-title":"Relapsing experimental allergic encephalomyelitis in the SJL\/J mouse","volume":"45","author":"Brown","year":"1981","journal-title":"Lab. Invest."},{"key":"10.1006\/jaut.1999.0358_RF4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4049\/jimmunol.126.3.819","article-title":"Delayed, relapsing experimental allergic encephalomyelitis in mice","volume":"126","author":"Lublin","year":"1981","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.1999.0358_RF5","first-page":"271","article-title":"Specific treatment of multiple sclerosis","volume":"2","author":"Silberberg","year":"1994","journal-title":"Clin. Neurosci."},{"key":"10.1006\/jaut.1999.0358_RF6","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/ana.410360724","article-title":"Rationale for immunotherapy in multiple sclerosis","volume":"36","author":"Whitaker","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1006\/jaut.1999.0358_RF7","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.4049\/jimmunol.148.6.1693","article-title":"Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation","volume":"148","author":"Karussis","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.1999.0358_RF8","first-page":"219","article-title":"Preventive and therapeutic effects of cyclosporin and valine2-dihydro-cyclosporin in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat","volume":"63","author":"Feurer","year":"1988","journal-title":"Immunology"},{"key":"10.1006\/jaut.1999.0358_RF9","first-page":"365","article-title":"Development of experimental allergic encephalomyelitis during steroid administration. Outcome of neurological immune-mediated disorders under immunosuppressive therapy","volume":"27","author":"Steiner","year":"1991","journal-title":"Isr. J. Med Sci"},{"key":"10.1006\/jaut.1999.0358_RF10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1749-6632.1986.tb20877.x","article-title":"Treatment of autoimmune disease with total lymphoid irradiation. Cellular and humoral mechanisms","volume":"475","author":"Strober","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"10.1006\/jaut.1999.0358_RF11","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1084\/jem.171.6.1943","article-title":"Prevention and treatment of murine allergic encephalomyelitis with T cell receptor V beta-specific antibodies","volume":"171","author":"Zaller","year":"1990","journal-title":"J Exp Med"},{"key":"10.1006\/jaut.1999.0358_RF12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00007611-199704000-00001","article-title":"Current and investigational therapies used to alter the course of disease in multiple sclerosis","volume":"90","author":"Miller","year":"1997","journal-title":"South Med J"},{"key":"10.1006\/jaut.1999.0358_RF13","doi-asserted-by":"crossref","unstructured":"Becker, C.C. Gidal, B.E. Fleming, J.O. Immunotherapy in multiple sclerosis, Part 1, Am. J. Health Syst. Pharm. 52, 1985, 2000","DOI":"10.1093\/ajhp\/52.18.1985"},{"key":"10.1006\/jaut.1999.0358_RF14","series-title":"Utilization and transformation of purine and pyrimidine compounds in microorganisms","first-page":"88","article-title":"Adenylate deaminase from Penicillium lanoso-viride 8D. Some properties of the enzyme","author":"Revelina","year":"1981"},{"key":"10.1006\/jaut.1999.0358_RF15","article-title":"The catalytic properties and biological activities of adenylate deaminase from Penicillium lanoso-viride","author":"Nikolajeva","year":"1982","journal-title":"Diss. Dr. Biol."},{"key":"10.1006\/jaut.1999.0358_RF16","first-page":"139","article-title":"Immunostimulating and antitumor potential of mould glycoprotein","volume":"88","author":"Zak","year":"1986","journal-title":"A. Sbornik. lekarsky."},{"key":"10.1006\/jaut.1999.0358_RF17","series-title":"Nucleases. Biological role and practical applications","first-page":"21","article-title":"Antitumor and immunomodulating properties of adenylate deaminase from Penicillium lanoso-viride 8D","author":"Nikolajeva","year":"1985"},{"key":"10.1006\/jaut.1999.0358_RF18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0162-3109(96)00142-7","article-title":"Protective effect of adenylate deaminase (from Penicillium lanoso-viride) against acute infections in mice","volume":"35","author":"Nikolajeva","year":"1996","journal-title":"Immunopharmacology."},{"key":"10.1006\/jaut.1999.0358_RF19","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.90.14.6400","article-title":"Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide)","volume":"90","author":"Karussis","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1006\/jaut.1999.0358_RF20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0022-510X(72)90124-4","article-title":"Studies on the pathogenesis of multiple sclerosis. 2\u2032, 3\u2032-Cyclic nucleotide 3\u2032\u2013phosphohydrolase as marker of demyelination and correlation of findings with lysosomal changes","volume":"15","author":"Riekkinen","year":"1972","journal-title":"J Neurol Sci."},{"key":"10.1006\/jaut.1999.0358_RF21","series-title":"Handbook of experimental immunology","article-title":"Complement technology. Chapter 39","author":"Harrison","year":"1986"},{"key":"10.1006\/jaut.1999.0358_RF22","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archderm.1983.01650350062019","article-title":"Delayed hypersensitivity skin testing. A review","volume":"119","author":"Ahmed","year":"1983","journal-title":"Arch Dermatol."},{"key":"10.1006\/jaut.1999.0358_RF23","first-page":"217","article-title":"Controlled trial at Proper-myl treatment in multiple sclerosis","volume":"5","author":"Cendrowski","year":"1971","journal-title":"Neurol Neurochir Pol."},{"key":"10.1006\/jaut.1999.0358_RF24","first-page":"83","article-title":"Changes in the immunological reactivity of patients with disseminated sclerosis treated by prednisolone and the preparation Proper-myl","volume":"2","author":"Jarosh","year":"1990","journal-title":"Vrach Delo."},{"key":"10.1006\/jaut.1999.0358_RF25","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1073\/pnas.93.14.7196","article-title":"Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit","volume":"14","author":"Sun","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1006\/jaut.1999.0358_RF26","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1006\/clin.1996.0139","article-title":"Treatment of autoimmune disease by oral tolerance to autoantigens","volume":"3","author":"Whitacre","year":"1996","journal-title":"Clin Immunol Immunopathol."},{"key":"10.1006\/jaut.1999.0358_RF27","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4049\/jimmunol.159.2.1036","article-title":"Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance","volume":"159","author":"Kennedy","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.1999.0358_RF28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.410050608","article-title":"Activity of 2\u2032,3\u2032-cyclic nucleotide 3\u2032-phosphohydrolase in human cerebrospinal fluid","volume":"6","author":"Banik","year":"1979","journal-title":"Ann Neurol."},{"key":"10.1006\/jaut.1999.0358_RF29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02834248","article-title":"2\u2032, 3\u2032-Cyclic nucleotide 3\u2032-phosphodiesterase activity in the cerebrospinal fluid of patients with demyelinating diseases","volume":"2","author":"Suda","year":"1984","journal-title":"Neurochem Pathol."},{"key":"10.1006\/jaut.1999.0358_RF30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0022-510X(81)90141-6","article-title":"Experimental allergic encephalomyelitis induced by basic protein with synthetic adjuvant in comparison with Freund's complete adjuvant. Role of antibodies in correlation with the clinicopathological features","volume":"52","author":"Mitsuzawa","year":"1981","journal-title":"J Neurol. Sci."},{"year":"1994","series-title":"Basic and clinical immunology","author":"D.P","key":"10.1006\/jaut.1999.0358_RF31"},{"key":"10.1006\/jaut.1999.0358_RF32","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1007\/BF00873696","article-title":"New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis","volume":"243","author":"Arnon","year":"1996","journal-title":"J. Neurol."},{"key":"10.1006\/jaut.1999.0358_RF33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.185.5.901","article-title":"A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis","volume":"185","author":"Falcone","year":"1997","journal-title":"J Exp Med"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684119990358X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684119990358X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:49:34Z","timestamp":1760255374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684119990358X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S089684119990358X"],"URL":"https:\/\/doi.org\/10.1006\/jaut.1999.0358","relation":{},"ISSN":["0896-8411"],"issn-type":[{"type":"print","value":"0896-8411"}],"subject":[],"published":{"date-parts":[[2000,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Experimental Autoimmune Encephalomyelitis With Adenylate Deaminase From Penicillium lanoso-viride","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/jaut.1999.0358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}